Purinergic Signaling Is a Novel Mechanism of the Cellular Response to Ionizing Radiation
- PMID: 26133701
- DOI: 10.1248/bpb.b15-00062
Purinergic Signaling Is a Novel Mechanism of the Cellular Response to Ionizing Radiation
Abstract
Recent studies suggest the effect of radiation is observed not only in irradiated cells but also in adjacent non-irradiated cells (bystander effect), although the mechanism has not yet been fully revealed. This bystander effect may be caused by intercellular communication via a gap junction or by messengers released from irradiated cells, such as reactive oxygen species, nitric oxide, or cytokines. However, an unknown mechanism is also possible in the bystander effect. On the other hand, it is known that extracellular ATP, ADP, uridine 5'-triphosphate (UTP), and uridine 5'-diphosphate (UDP), which are released from cells, act as intercellular signaling molecules by activating purinergic P2X and P2Y receptors (purinergic signaling). Recently, I have suggested these extracellular nucleotides may be novel mediators of a radiation-induced bystander effect, because our recent studies indicated that purinergic signaling is involved in important cellular responses to radiation. Our data indicate that ionizing irradiation causes activation of the transient receptor potential melastatin type 2 (TRPM2) channel, and then ATP is released from cells through the anion channel or connexin43 hemichannel mediated by the activation of a P2X7 receptor. The released nucleotides activate P2Y6 and P2Y12 receptors, which are involved in the DNA damage response after irradiation. Activation of the P2Y6 receptor is also involved in radiation-induced activation of the epithelial growth factor receptor-extracellular signal regulated protein kinase (EGFR-ERK)1/2 pathway and subsequent nuclear translocation of EGFR, which plays a role in DNA repair. Further, the induction of an antioxidant after irradiation is also mediated by the activation of the P2Y receptor. In conclusion, purinergic signaling could play an important role in the protective cellular response to ionizing irradiation.
Similar articles
-
Autocrine regulation of γ-irradiation-induced DNA damage response via extracellular nucleotides-mediated activation of P2Y6 and P2Y12 receptors.DNA Repair (Amst). 2012 Aug 1;11(8):657-65. doi: 10.1016/j.dnarep.2012.05.005. Epub 2012 Jun 9. DNA Repair (Amst). 2012. PMID: 22682873
-
Involvement of purinergic signaling in cellular response to gamma radiation.Radiat Res. 2010 Mar;173(3):298-309. doi: 10.1667/RR1732.1. Radiat Res. 2010. PMID: 20199215
-
Involvement of connexin43 hemichannel in ATP release after γ-irradiation.J Radiat Res. 2012 Jul;53(4):551-7. doi: 10.1093/jrr/rrs014. Epub 2012 Jun 12. J Radiat Res. 2012. PMID: 22843620 Free PMC article.
-
Control of epithelial transport via luminal P2 receptors.Am J Physiol Renal Physiol. 2003 Mar;284(3):F419-32. doi: 10.1152/ajprenal.00075.2002. Am J Physiol Renal Physiol. 2003. PMID: 12556361 Review.
-
Purinergic signaling in kidney disease.Kidney Int. 2017 Feb;91(2):315-323. doi: 10.1016/j.kint.2016.08.029. Epub 2016 Oct 22. Kidney Int. 2017. PMID: 27780585 Review.
Cited by
-
Evaluation of the role of mitochondria in the non-targeted effects of ionizing radiation using cybrid cellular models.Sci Rep. 2020 Apr 9;10(1):6131. doi: 10.1038/s41598-020-63011-w. Sci Rep. 2020. PMID: 32273537 Free PMC article.
-
Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells.Oncotarget. 2017 Oct 24;8(57):97331-97343. doi: 10.18632/oncotarget.21995. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228614 Free PMC article.
-
Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions.J Clin Med. 2020 Dec 18;9(12):4095. doi: 10.3390/jcm9124095. J Clin Med. 2020. PMID: 33353023 Free PMC article. Review.
-
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.J Exp Clin Cancer Res. 2022 Jul 15;41(1):222. doi: 10.1186/s13046-022-02430-1. J Exp Clin Cancer Res. 2022. PMID: 35836249 Free PMC article. Review.
-
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.Front Pharmacol. 2020 Mar 13;11:222. doi: 10.3389/fphar.2020.00222. eCollection 2020. Front Pharmacol. 2020. PMID: 32231563 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous